good open TSX-V 0.22 and at any time news from the FDA V4.0 We are now preparing for product launch and market entry for what we believe is a product that promises true benefits for patients, clinicians and healthcare providers. In the post on Linkein Hugh MacNaught President and CEO at Ventripoint Diagnostics Ltd. 5 days ago During the past several months Ventripoint has released VMS+
...more